Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK of 14C-ACT-246475 in Healthy Males
NCT03593278Phase 1Completed
- Sponsor
- Viatris
- Start
- Jul 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of selatogrel in acute myocardial infarction (AMI), sponsored by Viatris. Primary endpoint: Cumulative excretion of total 14C-radioactivity in urine and feces up to 54 days. Started Jul 2018; status: completed.
02
Drugs
selatogrel
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT03593278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593278.